Your browser doesn't support javascript.
loading
Structural and conformational determinants of macrocycle cell permeability.
Over, Björn; Matsson, Pär; Tyrchan, Christian; Artursson, Per; Doak, Bradley C; Foley, Michael A; Hilgendorf, Constanze; Johnston, Stephen E; Lee, Maurice D; Lewis, Richard J; McCarren, Patrick; Muncipinto, Giovanni; Norinder, Ulf; Perry, Matthew W D; Duvall, Jeremy R; Kihlberg, Jan.
Afiliação
  • Over B; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
  • Matsson P; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Tyrchan C; Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), a node at the Chemical Biology Consortium Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Artursson P; Respiratory, Inflammation and Autoimmunity Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
  • Doak BC; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Foley MA; Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), a node at the Chemical Biology Consortium Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Hilgendorf C; Department of Chemistry, Uppsala University, Uppsala, Sweden.
  • Johnston SE; Center for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
  • Lee MD; Drug Safety and Metabolism, Safety &ADME Translational Sciences, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
  • Lewis RJ; Center for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
  • McCarren P; Center for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
  • Muncipinto G; Respiratory, Inflammation and Autoimmunity Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
  • Norinder U; Center for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
  • Perry MW; Center for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
  • Duvall JR; Swedish Toxicology Sciences Research Center, Södertälje, Sweden.
  • Kihlberg J; Respiratory, Inflammation and Autoimmunity Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
Nat Chem Biol ; 12(12): 1065-1074, 2016 12.
Article em En | MEDLINE | ID: mdl-27748751
ABSTRACT
Macrocycles are of increasing interest as chemical probes and drugs for intractable targets like protein-protein interactions, but the determinants of their cell permeability and oral absorption are poorly understood. To enable rational design of cell-permeable macrocycles, we generated an extensive data set under consistent experimental conditions for more than 200 non-peptidic, de novo-designed macrocycles from the Broad Institute's diversity-oriented screening collection. This revealed how specific functional groups, substituents and molecular properties impact cell permeability. Analysis of energy-minimized structures for stereo- and regioisomeric sets provided fundamental insight into how dynamic, intramolecular interactions in the 3D conformations of macrocycles may be linked to physicochemical properties and permeability. Combined use of quantitative structure-permeability modeling and the procedure for conformational analysis now, for the first time, provides chemists with a rational approach to design cell-permeable non-peptidic macrocycles with potential for oral absorption.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Macrocíclicos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Macrocíclicos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article